Search University Hospitals Seidman Cancer Center for cancer-related clinical trials.

For infectious disease clinical trials, see current studies available through the University Hospitals Infectious Diseases Clinical Trials Unit.

Trial Name:

Cancer, Ovarian, Fallopian Tube or Peritoneal

Intro: This research study is designed study a treatment for ovarian, fallopian tube or peritoneal cancers.
Condition:  
Description: This research study is designed to study a treatment for ovarian, fallopian tube or peritoneal cancers.
The treatment uses the experimental drug, BAY 43-9006, in combination with two FDA-approved cancer treatment drugs, carboplatin and paclitaxel.
Criteria: Participants must be at least 18 years of age and must have recurrent, measurable, epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer that is considered platinum sensitive. Participants must have received prior therapy with a platinum-based regimen before study enrollment. Participants must have adequate bone marrow function and must not need an IV to stay hydrated or for nutritional support. Participants of childbearing potential must agree to use adequate contraception.
Contact: For information or to register for screening in this trial please call HealthMatch at (216) 844-5000, or complete and submit the form below.

Participant Confidentiality:

All information regarding participation in Clinical Trials is treated with the utmost confidentiality. University Hospitals Case Medical Center and the Division of Clinical Research recognize and respect the confidentiality of this information. Access to information related to clinical trials and their participants is restricted to authorized clinical trials personnel only.

Back